Cargando…
Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
The outbreak of coronavirus disease 2019 (COVID-19) has not only affected human health but also diverted the focus of research and derailed the world economy over the past year. Recently, vaccination against COVID-19 has begun, but further studies on effective therapeutic agents are still needed. Th...
Autores principales: | Shah, Masaud, Woo, Hyun Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245319/ https://www.ncbi.nlm.nih.gov/pubmed/34059561 http://dx.doi.org/10.14348/molcells.2021.0026 |
Ejemplares similares
-
Immune evasion mechanisms and therapeutic strategies in gastric cancer
por: Ma, En-Si, et al.
Publicado: (2022) -
The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
por: Shah, Masaud, et al.
Publicado: (2022) -
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
por: Shah, Masaud, et al.
Publicado: (2022) -
SARS‐CoV‐2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion
por: Quaglia, Federica, et al.
Publicado: (2022) -
Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
por: Shah, Masaud, et al.
Publicado: (2020)